Associations between clinicopathological prognostic factors and pAkt, pMAPK and topoisomerase II expression in breast cancer

Sadeleştirilmiş öğe sayfası
dc.contributor.authorIyikesici, Mehmet Salih
dc.contributor.authorBasaran, Gul
dc.contributor.authorDane, Faysal
dc.contributor.authorEkenel, Meltem
dc.contributor.authorYumuk, P. Fulden
dc.contributor.authorCabuk, Devrim
dc.contributor.authorTeomete, Mehmet
dc.contributor.authorTurhal, N. Serdar
dc.date.accessioned2025-10-16T15:33:32Z
dc.date.issued2014
dc.identifier.otherWOS:000341254800039
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9260
dc.publisherE-CENTURY PUBLISHING CORP
dc.sourceINTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
dc.subjectBreast cancer
dc.subjectmitogen activated protein kinase \\(MAPK\\)
dc.subjectAkt
dc.subjecttopoisomerase II
dc.subjecthuman epidermal growth factor receptor\\-2
dc.subjectneu \\(HER\\-2
dc.subjectneu\\)
dc.titleAssociations between clinicopathological prognostic factors and pAkt, pMAPK and topoisomerase II expression in breast cancer
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS
Load more